The 16th Scientific Meeting of the Association for Ocular Pharmacology and Therapeutics was successfully held

• 2023-02-03 15:18:54

Opening ceremony

The 16th Scientific Meeting of the Association for Ocular Pharmacology and Therapeutics (AOPT) was held in Shenyang, China and Indianapolis, the United States, from August 12 to 13, 2023. It was the first time that China hosted this international academic event.

The AOPT Annual meeting in China was hosted by He Vision Group and Liaoning He University and co-organized by the Eye Hospital of China Academy of Chinese Medical Sciences, Sun Yat-sen Eye Center of Zhongshan Ophthalmic University, Eye Center of Shanghai General Hospital, Henan Provincial People’s Hospital, National Clinical Medical Research Center for Eye Diseases, and State Key Laboratory of Ophthalmology. The conference aims to build a comprehensive exchange and integration platform for clinical medical institutions, drug research institutions, clinical trial institutions and drug production institutions from basic research to clinical research, from laboratory to industrial transformation, from clinical demand to capital support, and jointly promote the industrial transformation of ophthalmic drugs in China.

Professor He Wei, chairman of the AOPT China organizing committee, gave a welcome speech 

Professor He Wei, Chairman of the Organizing Committee of the AOPT Annual Meeting in China, board member of the International Agency for the Prevention of Blindness, and deputy leader of the National Technical Guidance Committee for the Prevention of Blindness, said in his speech that AOPT has made outstanding contributions to promoting research and scientific progress in the field of pharmacology and treatment of eye diseases since its establishment. The conference has built a good cooperation and exchange platform for ophthalmic pharmaceutical workers, ophthalmologists, researchers, health industry associations and investment experts, which is of great and far-reaching significance to promoting the innovation and development of the ophthalmic pharmaceutical industry.

As a national drug clinical trial institution, He Eye Specialist Hospital undertakes clinical research work on new drugs every year. Jointly established China's first eye gene bank with BGI and carried out ophthalmic gene-drug research and development based on the gene bank; The Institute of Eye Genetics has been established in Boao Lecheng, Hainan, to carry out international advanced gene therapy and clinical application of drugs, and provide better medical treatment for more patients with genetic eye diseases.

Wang Shusheng, vice president of AOPT, initiator of the AOPT China conference and professor at Tulane University, gave a speech

Wang Shuseng, vice president of the AOPT Association, initiator of the AOPT China Conference, and professor of Tulane University, USA, introduced the general situation of the AOPT to the participating experts. He hoped that AOPT could become a bridge to promote more exchanges and cooperation between Chinese and foreign scientists in eye treatment.

Professor Fan Xianqun, the Chinese Academy of Engineering and the Academia Ophthalmologica Internationalis academician, sent a congratulations video

Professor Yao Ke, chairman of the Ophthalmology Branch of Chinese Medical Association and academician of the Academia Ophthalmologica Internationalis, sent a congratulations video

Professor Fan Xianqun, the Chinese Academy of Engineering and the Academia Ophthalmologica Internationalis academician, and Professor Yao Ke, chairman of the Ophthalmology Branch of Chinese Medical Association and academician of the Academia Ophthalmologica Internationalis, respectively sent congratulations to the AOPT conference held for the first time in China and expressed expectations for the conference.

At the conference, more than 40 experts from domestic clinical, ophthalmic drug research, real world research, health industry associations and investment fields conducted in-depth discussions on topics such as the transformation and innovative development of traditional Chinese medicine achievements, research and development and transformation of ophthalmic innovative drugs, clinical research of new drugs, real world research of ophthalmic drugs, and biomedical industry integration, to contribute experience and wisdom to promoting the discipline construction of ophthalmic pharmacology and therapeutics, and enhancing the research of new ophthalmic drugs and the transformation of technological achievements. In particular, the conference established a special forum on the transformation and innovation of traditional Chinese medicine achievements, and the participating experts focused on the treatment mechanism of traditional Chinese medicine and the new progress in the transformation and innovation of results, which has become a major feature of this AOPT conference different from previous conferences.

It attracted more than 200 domestic ophthalmologists to attend the event, and more than 6,000 people learned online through network broadcast, and carried out warm exchanges and discussions with experts online and offline. As an important bridge and link, this conference has established a platform for exchange and cooperation, attracted more experts, scholars, research institutes, and various enterprises to discuss and cooperate for common development, and has great and far-reaching significance in promoting the faster development of ophthalmic pharmacology and therapeutics with Chinese characteristics, and enhancing the innovation and development of the ophthalmic medicine industry. In the future, He Eye Specialist Hospital will continue to host various domestic and international academic conferences in ophthalmology, contributing wisdom and strength to building a visual China, a healthy China, and a human health community!